Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-04

Clinical Trial Update: Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether postoperative ketorolac affects bone healing after joint fusion; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Rothman Institute Orthopaedics | Conditions: Ketorolac, Joint Fusion | Phase 3 | Status: UNKNOWN